John Lothian News interviewed Michael Riddle, CEO of Eris Innovations, and Agha Mirza, managing director and global head of rates and OTC products for the CME Group about the success of the Eris SOFR products trading on the CME.
JLN asked about the origin story of the Eris products and when they began to trade on the CME.
We asked about the recent events that have driven the growth of the products. We asked about the impact of the regional banking crisis on the products.
Riddle and Mirza also discussed who the users of the products are and what plans Eris Innovations has to extend the product mix in the next three to five years.
Why has volume significantly increased in the open outcry trading pits at the CME Group in recent months compared to before the pits were...
Phil Mackintosh, Chief Economist at Nasdaq, discusses some of the biggest takeaways learned from 2020, as well as what to expect from 2021.
Paving the Way for 2024 Digital Asset Industry Optimism The Financial Industry Regulatory Authority ("FINRA") today approved Prometheum Capital LLC to operate as a...
